We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Identifies Parkinson’s in Patients at Risk of Dementia

By HospiMedica International staff writers
Posted on 26 Mar 2014
According to new research out of Canada, it may now be possible to identify which first-stage Parkinson’s disease (PD) patients who will go on to develop dementia. More...


The study was conducted at the Institut Universitaire de Geriatrie de Montreal (Montreal, QC, Canada) by Dr. Oury Monchi, PhD, and his postdoctoral student, Dr. Alexandru Hanganu, MD, PhD, both of whom are affiliated with Universite de Montreal. Their findings were published in the February 2014 issue of the journal Brain.

Although PD is typically tied to motor difficulties such as trembling or rigidity or trembling, individuals with this disease basically have a six times greater chance of developing dementia compared to the rest of the population. In this first longitudinal study in this field, 32 patients in the first stages of PD were followed for 20 months. Some of the patients had mild cognitive deficiencies while others did not. A control group of 18 healthy people were also monitored.

“Using magnetic resonance imaging [MRI], we found thinning in certain cortical areas as well as subcortical atrophy in the grey matter of subjects with mild cognitive impairments. Thanks to our longitudinal approach, we were able to observe that this thinning speeds up in conjunction with the increase in cognitive problems,” explained Dr. Monchi. This specific brain deterioration combined with the early presence of mild cognitive impairments could serve as markers for the development of dementia.

Dr. Monchi stressed the significance of these findings. “This study opens the door to further research, for example, on medication or on nonpharmacological approaches such as transcranial magnetic stimulation. It’s important for these patients to be identified very quickly before they develop dementia so that a therapeutic approach can be adapted to their specific needs.”

Related Links:

Institut Universitaire de Geriatrie de Montreal



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Wound Irrigation Solution
Prontosan®
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.